Oxford Science Enterprises announces successful signing of a NAV Financing facility, up to £175 million in size, provided by Deutsche Bank and Goldman Sachs

Oxford Science Enterprises (OSE), an independent investment company founded in 2015 to invest in exceptional science companies in the life sciences, healthtech and deeptech sectors, announced the successful signing of a NAV Financing facility, up to £175 million in size, provided by Deutsche Bank and Goldman Sachs.

OSE’s mission is to create and back businesses based on world-leading science and technology, via its unique partnership with the University of Oxford.

The Net Asset Value (NAV) financing facility – initially £100 million in size, with the potential to increase to £175 million – closed in March 2025 and was provided by tier one lenders Deutsche Bank and Goldman Sachs at an attractive cost of capital for OSE. It marks a significant milestone in OSE’s growth trajectory to build the next generation of world changing companies.

The capital from this financing will be deployed into new investments and used to support further growth in OSE’s existing portfolio of over 100 companies. The success of this transaction underscores investor confidence in OSE’s platform and unlocks new strategic opportunities for both the company and its portfolio.

OSE is supported by blue chip institutional shareholders from around the world, including M&G, Lansdowne Partners, Braavos Investment, Temasek, Oman Investment Authority, Qatar Investment Authority, GV and the Wellcome Trust. OSE has delivered strong returns to investors since inception, with over £334 million realised to date at an average 7x gross return on exits.

Rede is delighted to have partnered with OSE to complete this highly successful transaction.